Loading cancer entity…
Loading cancer entity…
Clinical trials
190 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06333899 | Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion | recruiting | Early Phase 1 | 15 | Nationwide Children's HospitalOTHER | 6 | Jun 29, 2026 | clinicaltrials |
| NCT04655404 | A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion | recruiting | Early Phase 1 | 15 | Nationwide Children's HospitalOTHER | 5 | Mar 18, 2026 | clinicaltrials |
| NCT03893487 |
| Fimepinostat in Treating Brain Tumors in Children and Young Adults(PNOC016) |
| active not recruiting |
| Early Phase 1 |
| 30 |
| Sabine Mueller, MD, PhDOTHER |
| 2 |
| Jul 11, 2025 |
| clinicaltrials |
Data updated 22 days agoSource updated Jun 29, 2026source: clinicaltrials